<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00862290</url>
  </required_header>
  <id_info>
    <org_study_id>microRNA_sepsis</org_study_id>
    <nct_id>NCT00862290</nct_id>
  </id_info>
  <brief_title>Circulating microRNAs as Biomarkers of Sepsis</brief_title>
  <official_title>Diagnostic and Predictive Value of Circulating microRNAs During Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MicroRNA has been demonstrated to play a crucial role in regulating cell processes. Recently,
      microRNA was identified to exist in human serum or plasma, and it might be related to certain
      diseases. Several microRNAs are involved in sepsis, such as miR-146, miR-155, and so on. But
      whether serum miR-146 is present in serum of septic patients remains unknown. The present
      study was designed to identify the existence of specific microRNAs, which might be new
      markers for sepsis and its prognosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Relative amount of circulating microRNAs</measure>
    <time_frame>On the second day of diagnosis of sepsis in ICU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum levels of CRP and IL-6</measure>
    <time_frame>On the second day of diagnosing sepsis</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apache II score and death</measure>
    <time_frame>On the second day of diagnosis of sepsis</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>sepsis group</arm_group_label>
    <description>Patients who develop sepsis in the ICU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SIRS group</arm_group_label>
    <description>Patients who develop SIRS after cardiac surgery with cardiopulmonary bypass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>normal healthy volunteers</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood of septic patients is collected on the second day when they are diagnosed with sepsis
      in ICU. Blood of SIRS patients is collected on the second day when they are diagnozed with
      SIRS after cardiac surgery with cardiopulmonary bypass.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients who develop sepsis and SIRS
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who develop sepsis and undergo abdominal surgery

          -  patients who develop SIRS after cardiac surgery with cardiopulmonary bypass

        Exclusion Criteria:

          -  patients with a primary diagnosis of acute pancreatitis

          -  patients with cirrhosis or renal dysfunction

          -  patients with dyscrasia

          -  patients with autoimmunity diseases

          -  patients with severe cardiac and pulmonary diseases

          -  patients with hematological diseases

          -  patients who had organ dysfunction after cardiac surgery with cardiopulmonary bypass
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ke-ming Zhu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Intensive Care Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Changhai Hospital, Second Military Medical University</name>
      <address>
        <city>Shanghai</city>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, Zhu KM. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun. 2010 Mar 26;394(1):184-8. doi: 10.1016/j.bbrc.2010.02.145. Epub 2010 Feb 24.</citation>
    <PMID>20188071</PMID>
  </results_reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2009</study_first_submitted>
  <study_first_submitted_qc>March 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2009</study_first_posted>
  <last_update_submitted>May 2, 2013</last_update_submitted>
  <last_update_submitted_qc>May 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Jia-feng Wang</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>microRNA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

